Cristina L Ronchi
Cristina L Ronchi, MD, PhD is an expert in Endocrinology at University Hospital Würzburg (Germany). As of October 2026, ScienceLeadR ranks Cristina L Ronchi in the top 1% of experts worldwide for Adrenal Gland Neoplasms, Adrenal Gland Diseases and Endocrine Gland Neoplasms. Cristina L Ronchi has authored 272 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 780 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Oncology - Biochemistry - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2002 - 2026
Number : 272
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas. PMID 42592842 — cells, adrenal glands, hormones, cyclins, cell line, adrenocortical carcinoma, therapeutics, apoptosis, endocrine system diseases | Eur J Endocrinol | 2026 | 0 |
| A multistakeholder call for belzutifan biomarker data in advanced pheochromocytoma and paraganglioma. PMID 42481355 — paraganglioma, pheochromocytoma, biomarkers, hormones, endocrine glands, endocrine system diseases | Trends Endocrinol Metab | 2026 | 1 |
| Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study. PMID 42413529 — diabetes mellitus, hypertension, mortality, incidental findings, cohort studies, risk factors, diagnosis, hydrocortisone | Lancet Diabetes Endocrinol Top journal | 2026 | 2 |
| Impact of diagnosis and targeted interventions on the quality of life and neuropsychiatric outcomes of patients with adrenal tumours: a systematic review. PMID 42011921 — quality of life, hormones, adrenocortical carcinoma, diagnosis, patient reported outcome measures, endocrine system diseases | Eur J Endocrinol | 2026 | 0 |
| Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes-an ENSAT cohort study. PMID 41812315 — neoplasms, cohort studies, propensity score, adrenocortical carcinoma, prognosis, adrenal gland neoplasms | ESMO Open | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map